Login to your account
Don’t have an account?
Create a Free Account
E-Only Articles
Cardiotrophin-1, an antiinflammatory cytokine; is there a therapeutic role in orthotopic liver transplantation?
Living donor liver transplantation was introduced in 1988 [1–3]. Since its first clinical application, living donor liver transplantation has been gradually accepted [4] for patients with end-stage liver disease. In recent years, living donor or cadaveric split liver transplantation has been a valuable alternative in solving the problem of organ shortage and has shown significantly improved clinical outcomes [5]. With reduction of graft size, the chance of primary graft nonfunction is increased.
